Harvard Bioscience Operating Income 2012-2026 | HBIO

Harvard Bioscience operating income from 2012 to 2026. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Harvard Bioscience Annual Operating Income
(Millions of US $)
2025 $-49
2024 $-6
2023 $2
2022 $-7
2021 $2
2020 $0
2019 $0
2018 $1
2017 $-1
2016 $-3
2015 $-2
2014 $7
2013 $2
2012 $8
2011 $8
Harvard Bioscience Quarterly Operating Income
(Millions of US $)
2026-03-31 $-1
2025-12-31 $2
2025-09-30 $0
2025-06-30 $-1
2025-03-31 $-50
2024-12-31 $0
2024-09-30 $-2
2024-06-30 $-2
2024-03-31 $-2
2023-12-31 $0
2023-09-30 $-1
2023-06-30 $1
2023-03-31 $2
2022-12-31 $0
2022-09-30 $-4
2022-06-30 $4
2022-03-31 $-7
2021-12-31 $2
2021-09-30 $1
2021-06-30 $0
2021-03-31 $0
2020-12-31 $3
2020-09-30 $0
2020-06-30 $1
2020-03-31 $-3
2019-12-31 $2
2019-09-30 $-1
2019-06-30 $0
2019-03-31 $0
2018-12-31 $2
2018-09-30 $1
2018-06-30 $0
2018-03-31 $-1
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $-1
2016-09-30 $-1
2016-06-30 $-1
2016-03-31 $0
2015-12-31 $0
2015-09-30 $-1
2015-06-30 $0
2015-03-31 $-1
2014-12-31 $2
2014-09-30 $1
2014-06-30 $2
2014-03-31 $1
2013-12-31 $-1
2013-09-30 $0
2013-06-30 $1
2013-03-31 $1
2012-12-31 $5
2012-09-30 $0
2012-06-30 $1
2012-03-31 $1
2011-12-31 $4
2011-09-30 $0
2011-06-30 $3
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.019B $0.087B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.722B 20.54
Kewaunee Scientific (KEQU) United States $0.100B 8.24